Larimar Therapeutics Inc. (LRMR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Larimar Therapeutics Inc.

    NASDAQ: LRMR · Real-Time Price · USD
    3.94
    0.07 (1.81%)
    At close: Sep 05, 2025, 3:59 PM
    4.00
    1.41%
    After-hours: Sep 05, 2025, 07:15 PM EDT

    Larimar Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 318K 311K 272K 326K
    Gross Profit
    		 -318K -311K -272K -326K
    Operating Income
    		 -90.89M -41.76M -36.53M -50.47M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -80.6M -36.95M -35.35M -50.64M
    Net Income
    		 -80.6M -36.95M -34.18M -50.31M
    Selling & General & Admin
    		 17.61M 14.09M 12.28M 12.07M
    Research & Development
    		 72.96M 27.36M 24.25M 38.4M
    Other Expenses
    		 318K n/a n/a -171K
    Operating Expenses
    		 90.89M 41.76M 36.53M 50.47M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 90.89M 41.76M 36.53M 50.47M
    Income Tax Expense
    		 n/a n/a -1.17M -326K
    Shares Outstanding (Basic)
    		 61.26M 43.9M 25.76M 17.16M
    Shares Outstanding (Diluted)
    		 61.26M 43.9M 25.76M 17.16M
    EPS (Basic)
    		 -1.32 -0.84 -1.33 -2.93
    EPS (Diluted)
    		 -1.32 -0.84 -1.33 -2.93
    EBITDA
    		 -80.29M -41.45M -35.08M -50.14M
    EBIT
    		 -80.6M -41.76M -36.53M -50.64M
    Depreciation & Amortization
    		 318K 311K 272K 326K

    Add to Watchlist